HEAD & NECK CANCERS

Latest News

Petosemtamab With Pembrolizumab Generates Early Clinical Efficacy in Select HNSCC
Petosemtamab With Pembrolizumab Generates Early Clinical Efficacy in Select HNSCC

June 4th 2024

Frontline treatment with petosemtamab and pembrolizumab produced early clinical efficacy in patients with recurrent or metastatic head and neck squamous cell carcinoma.

Perioperative Chemo With FLOT Improves OS in Resectable Esophageal Cancer
Perioperative Chemo With FLOT Improves OS in Resectable Esophageal Cancer

June 3rd 2024

NT219 Delivers Safety Responses in SCCHN
NT219 Delivers Safety Responses in SCCHN

May 15th 2024

Versamune HPV/Pembrolizumab Meets Primary End Point in HPV16+ HNSCC Study
Versamune HPV/Pembrolizumab Meets Primary End Point in HPV16+ HNSCC Study

May 14th 2024

9MW2821 Gains FDA Orphan Drug Designation in Esophageal Cancer
9MW2821 Gains FDA Orphan Drug Designation in Esophageal Cancer

May 9th 2024

More News